Literature DB >> 23550775

Phosphohistone-H3 and Ki-67 immunostaining in cutaneous pilar leiomyoma and leiomyosarcoma (atypical intradermal smooth muscle neoplasm).

Munir H Idriss1, Viktoryia Kazlouskaya, Saurabh Malhotra, Christian Andres, Dirk M Elston.   

Abstract

BACKGROUND: The mitotic index is important in the assessment of tumors such as leiomyoma (LM) and leiomyosarcoma (LMS), which may exhibit a range of cytological atypia. The mitotic marker phosphohistone-H3 (PHH3) was shown to improve interobserver and intraobserver variability in many tumors.
MATERIALS AND METHODS: We evaluated the mitotic index in 20 pilar LM and cutaneous LMS using PHH3 and hematoxylin and eosin (H&E)-stained sections. Ki-67 staining characteristics of the tumors were also assessed.
RESULTS: Mitotic figures were more easily identified within PHH3 sections. The mitotic index per 10 high power fields (HPF) on the PHH3 stain was slightly higher than H&E both in the LM (mean 0.1, range 0-1 vs. mean 0) and LMS groups (mean 8.6 vs. 8.0 with range of 1-24 for both stains). The difference in mitotic index between the two stains was not statistically significant in either group (p = 0.7). The Ki-67 proliferative index showed a statistically significant correlation with a diagnosis of LMS.
CONCLUSION: PHH3 immunostain can simplify counting of mitotic figures in cutaneous smooth muscle neoplasms, especially those with many pyknotic nuclei, and may help to reduce interobserver variability. Ki-67 staining may also be of help in establishing a diagnosis of LMS.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23550775     DOI: 10.1111/cup.12127

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  7 in total

1.  Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Authors:  Eleonora Duregon; Adele Cassenti; Alessandra Pittaro; Laura Ventura; Rebecca Senetta; Roberta Rudà; Paola Cassoni
Journal:  Neuro Oncol       Date:  2015-02-01       Impact factor: 12.300

2.  Phosphohistone H3: implications for clinical practice and risk assessment in meningioma.

Authors:  Adriana Olar
Journal:  Neuro Oncol       Date:  2015-03-25       Impact factor: 12.300

3.  Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.

Authors:  Arnaud Uguen; Gwenaël Conq; Laurent Doucet; Matthieu Talagas; Sebastian Costa; Marc De Braekeleer; Pascale Marcorelles
Journal:  Virchows Arch       Date:  2015-04-01       Impact factor: 4.064

4.  Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Authors:  Adriana Olar; Khalida M Wani; Erik P Sulman; Alireza Mansouri; Gelareh Zadeh; Charmaine D Wilson; Franco DeMonte; Gregory N Fuller; Kenneth D Aldape
Journal:  Brain Pathol       Date:  2014-10-29       Impact factor: 6.508

5.  Leiomyoma on nasal dorsum.

Authors:  Hwan Jun Choi; Kyu Hwa Jung; Jee Hye Lee
Journal:  Arch Plast Surg       Date:  2015-01-14

6.  Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma.

Authors:  Jiang Chen; Tong Ji; Di Wu; Shi Jiang; Jie Zhao; Hui Lin; Xiujun Cai
Journal:  Cell Death Dis       Date:  2019-05-29       Impact factor: 8.469

7.  Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.

Authors:  Lik Hang Lee; Hua Yang; Gilbert Bigras
Journal:  Sci Rep       Date:  2014-05-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.